Partnership to Improve Patient Care

  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • Blog
    • PIPC Patients' Blog
    • Chairman's Corner
    • PIPC Weekly Update
    • The Data Mine
  • Newsroom
    • PIPC in the News
    • Press Releases
    • Open Letter: We Deserve a Voice
  • Events
    • PIPC Forum 2022
    • Discrimination & Health Care
    • C & GT Webinar
    • ICER COVID Webinar
    • Value Our Health Briefing
    • QALY Briefing
    • QALY Panel
    • Past Webinars >
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • Blog
    • PIPC Patients' Blog
    • Chairman's Corner
    • PIPC Weekly Update
    • The Data Mine
  • Newsroom
    • PIPC in the News
    • Press Releases
    • Open Letter: We Deserve a Voice
  • Events
    • PIPC Forum 2022
    • Discrimination & Health Care
    • C & GT Webinar
    • ICER COVID Webinar
    • Value Our Health Briefing
    • QALY Briefing
    • QALY Panel
    • Past Webinars >
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010

The PIPC Blog

Chairman's Corner: Prioritizing Health Care: Patient or Payer First?

9/5/2017

 
Picture
In an op-ed published in RealClearHealth, PIPC Chairman Tony Coelho examines the limitations of quality-adjusted-life-years (QALYs) and how this tools for value-assessment may systematically discriminate against patients and individuals with disabilities. As he writes, "Underlying all this is the key question we must ask ourselves when considering any policy related to the payment and delivery of health care: for whom are we creating this policy? Who is the ultimate stakeholder? If the answer is not the people served by health systems -- patients and people with disabilities -- then we have a serious problem."

As Chairman Coelho explains, "QALYs have significant methodological limitations known to disadvantage people with disabilities and serious chronic conditions for whom 'optimal health' may not be achieved even with treatment, a fact widely recognized by patients, policymakers, and even health economists.... Despite deep-seated concerns, research based on QALYs serves as the foundation for insurance coverage decisions, both public and private. Academics, like those employed by the Institute for Clinical Effectiveness Review (ICER), use QALYs to determine whether the extra dollar on health care spent is worth it. Insurers and policymakers use QALYs to determine whether we are worth it."
Prioritizing Health Care: Patient or Payer First?​

By: Congressman Tony Coelho

This has been a tough year for patients and people with disabilities, in more ways than many recognize. As the primary author of the Americans with Disabilities Act (ADA) and a patient with epilepsy, I am frustrated that policymakers continue to ignore how their policies discriminate against patients and people with disabilities. One example looming under the radar is the ongoing use of quality-adjusted-life-years (QALYs) developed by health economists to compare the cost effectiveness of health care treatments, and now used to limit care to veterans.
​
QALYs have significant methodological limitations known to disadvantage people with disabilities and serious chronic conditions for whom “optimal health” may not be achieved even with treatment, a fact widely recognized by patients, policymakers, and even health economists. The U.S. Department of Health and Human Services cited in 1992 that Oregon’s use of QALYs to determine coverage potentially violates the ADA.

Despite deep-seated concerns, research based on QALYs serves as the foundation for insurance coverage decisions, both public and private. Academics, like those employed by the Institute for Clinical Effectiveness Review (ICER), use QALYs to determine whether the extra dollar on health care spent is worth it. Insurers and policymakers use QALYs to determine whether we are worth it.

Congress banned the Patient Centered Outcomes Research Institute (PCORI) from using QALYs to determine treatment value, choosing instead to measure effectiveness based on outcomes that matter to patients, ranging from clinical to quality of life. Also, Medicare cannot use QALYs to restrict coverage. Last year, after strong opposition from patients, CMS had to abandon a proposal to use ICER’s cost-effectiveness reviews in Medicare -- an attempt to sidestep the Medicare law.

Despite efforts to improve health care to veterans in the wake of some very public concerns about the quality and accessibility of its system, ICER announced the Veterans Administration (VA) will rely on its QALY-based cost effectiveness reports to determine drug formularies. This further entrenches the VA’s coverage decisions based on what is cost effective to the payer in the short term, not what is clinically effective for veterans in the long term. With constricting budgets, some State Medicaid programs also aggressively use cost-effectiveness thresholds to limit access for low-income patient populations. We also find ourselves defending PCORI and the need for comparative clinical effectiveness research that measures the impact of treatments on outcomes that matter to patients, as defined by patients, as opposed to defining treatment value based on payer-centric cost-based analyses. Cost effectiveness comparisons do not consider many non-medical costs borne by patients, families and caregivers and ironically are not always so cost effective in the real world.

Underlying all this is the key question we must ask ourselves when considering any policy related to the payment and delivery of health care: for whom are we creating this policy? Who is the ultimate stakeholder? If the answer is not the people served by health systems -- patients and people with disabilities -- then we have a serious problem.

If Congress and the administration want to put “patients first” and drive “patient-centered” policies, their credibility hinges on actually partnering with patients and people with disabilities. If the next iteration of health care legislation does not have the support of patients or people with disabilities, that’s a sure sign it’s really not about improving their health care. If our health care programs want to deliver better and more accessible care to active duty military and their dependents, as well as those retired from the Armed Services, patients and people with disabilities that have served this country must be at the table when coverage is determined, instead of ivory tower academics seeking to ration care based on short sighted cost effectiveness comparisons. Finally, to be truly innovative, the Innovations Office for Medicare and Medicaid must follow the lead of the Food and Drug Administration and PCORI by creating a meaningful patient engagement infrastructure that goes beyond “token” engagement, and rely on patients and people with disabilities to co-create alternative payment models that achieve value to the patient. 

There are many stakeholders in health care, ranging from providers, insurers, innovators, information technology developers, and more. But if the nation’s policies aren’t serving our primary stakeholder -- the patient -- then we aren’t doing our job.

Comments are closed.

    Topics

    All
    Alternative Payment Models
    Chairman's Corner
    Patient Centered Research
    PIPC In The News
    PIPC Patient Blog
    PIPC Weekly Update
    Press Releases
    The Data Mine
    Value Frameworks

    Archives

    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    April 2013
    March 2013
    December 2012
    November 2012
    February 2012
    September 2011
    August 2011
    July 2011
    May 2011
    March 2011
    November 2010
    October 2010
    September 2010
    August 2010
    April 2010
    March 2010
    February 2010
    December 2009
    September 2009
    July 2009
    June 2009
    May 2009
    February 2009
    January 2009
    December 2008

About PIPC
The Issues
Resources
Blog
In the News
Press Releases
Contact Us
100 M Street, SE – Ste. 750
Washington, DC 20003